Recent transactions make clear that large pharmaceutical companies now view rare disease as a core area for sustained growth, rather than episodic deal-making. BioMarin’s acquisition of Amicus ...

In exploring barriers in rare disease research and drug development, experts highlight a lack of robust models, limited trial ...

This study presents a valuable finding on the mutational order for common alterations in colorectal cancer. The evidence of in vitro growth assays comparing mutations is solid, although inclusion of ...

When floods sweep through southern Africa, the most visible damage is immediate: homes washed away, crops destroyed, clinics disrupted, families displaced. These images dominate headlines and ...

Thanks to advances in imaging and diagnostic technologies, clinicians can now detect many genetic disorders in the womb, opening the door to fetal therapies. This article will discuss how prenatal ...

Understanding the clinical overlap between vector-borne infections and pediatric acute-onset neuropsychiatric syndromes—and a ...

Two UTRGV professors from the School of Integrative Biological and Chemical Sciences are part of a multi-institutional collaboration ...

A case report demonstrating sequential neurorepair, lipid repletion, microbiome stabilization, and mitochondrial support in ...

This important study implicates that changes in cell regulation may contribute to the evolution of multicellularity. The evidence supporting the conclusions is convincing, with rigorous methods used ...